James M. Eudicone, MS, MBA
- 8Articles
- 27.3KReads
- 2007–2014Active
- 37Collaborators
- 179Citations
About
James M. Eudicone, MS, MBA, has authored multiple articles published between 2007 and 2014 focusing on the clinical applications of aripiprazole in psychiatric disorders. His work encompasses bipolar disorder, major depressive disorder, schizophrenia and schizoaffective disorders, child and adolescent psychiatry, neurology, and sexual dysfunction. Eudicone's research includes randomized controlled trials and post hoc analyses evaluating aripiprazole's efficacy, safety, metabolic effects, and impact on functional outcomes across these conditions.
Publications
Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies
December 20, 2012
Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies
January 13, 2011
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
